VALOTI, ERMANNO
 Distribuzione geografica
Continente #
EU - Europa 8.575
NA - Nord America 4.338
AS - Asia 2.455
SA - Sud America 88
Continente sconosciuto - Info sul continente non disponibili 44
OC - Oceania 33
AF - Africa 23
Totale 15.556
Nazione #
US - Stati Uniti d'America 4.257
GB - Regno Unito 3.017
IT - Italia 1.922
CN - Cina 1.251
DE - Germania 1.079
SE - Svezia 909
FR - Francia 317
IN - India 309
TR - Turchia 279
RU - Federazione Russa 245
KR - Corea 241
IE - Irlanda 231
UA - Ucraina 206
EU - Europa 161
DK - Danimarca 153
FI - Finlandia 130
NL - Olanda 113
SG - Singapore 79
CA - Canada 66
HK - Hong Kong 64
JP - Giappone 58
ES - Italia 56
VN - Vietnam 52
BE - Belgio 46
PH - Filippine 44
CO - Colombia 43
GR - Grecia 39
CH - Svizzera 32
AU - Australia 29
RO - Romania 27
BR - Brasile 24
ID - Indonesia 22
CL - Cile 15
PL - Polonia 15
IR - Iran 10
MX - Messico 10
MY - Malesia 10
AT - Austria 8
SA - Arabia Saudita 8
EG - Egitto 7
SC - Seychelles 6
TW - Taiwan 6
ZA - Sudafrica 6
JO - Giordania 5
CZ - Repubblica Ceca 4
IL - Israele 4
NZ - Nuova Zelanda 4
PE - Perù 4
CR - Costa Rica 3
EE - Estonia 3
LU - Lussemburgo 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
BD - Bangladesh 2
BG - Bulgaria 2
DZ - Algeria 2
HR - Croazia 2
HU - Ungheria 2
MT - Malta 2
PK - Pakistan 2
RS - Serbia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
EC - Ecuador 1
GE - Georgia 1
GT - Guatemala 1
IQ - Iraq 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PR - Porto Rico 1
TH - Thailandia 1
TN - Tunisia 1
Totale 15.675
Città #
Southend 2.821
Chandler 654
Milan 585
Hanover 341
Princeton 290
Beijing 280
Seattle 277
Mountain View 230
Dublin 227
Ann Arbor 218
Ashburn 217
Wilmington 210
Dearborn 187
Nanjing 155
Redmond 138
Fairfield 136
Jacksonville 113
Des Moines 98
Woodbridge 94
Bengaluru 85
Boardman 82
Sakarya 82
Redwood City 72
Cambridge 66
Houston 62
Jinan 60
Shenyang 60
Munich 58
Guangzhou 53
Andover 52
Nanchang 51
Seoul 50
Shanghai 50
Somerville 50
Hong Kong 48
Serra 47
Bogotá 42
Phoenix 42
Hebei 40
Toronto 40
Brussels 38
Berlin 37
Frankfurt am Main 37
Rome 37
Hangzhou 36
Medford 35
Changsha 34
Petina 34
Athens 31
Ningbo 31
Mumbai 30
Tianjin 28
Helsinki 26
Kiez 25
Bologna 23
Nürnberg 23
Dong Ket 20
San Diego 20
Sunnyvale 20
Zhengzhou 20
Bühl 19
Los Angeles 19
Madrid 18
Grafing 17
Tokyo 17
Costa Mesa 16
Pune 16
Bitonto 15
Eitensheim 15
Istanbul 15
Hamburg 14
Hefei 14
Turin 14
Auburn Hills 13
Bangalore 13
Hyderabad 13
Kunming 13
New York 13
Pavia 13
Roxbury 13
San Jose 13
Taizhou 13
Zurich 13
Haikou 12
Jiaxing 12
Odernheim 12
Verona 12
Catania 11
London 11
Ticengo 11
Barcelona 10
Brescia 10
Cinisello Balsamo 10
Fremont 10
Fuzhou 10
Rho 10
Singapore 10
Siracusa 10
Amsterdam 9
Bergamo 9
Totale 9.566
Nome #
Tecno cannabis: sintesi e caratterizzazione analitica di JWH-018 e JWH-073 574
Synthesis and alpha4beta2 nicotinic affinity of 2-pyrrolidinylmethoxyimines and prolinal oxime ethers 473
ANALOGHI STRUTTURALI DEL WB 4101: PROGETTAZIONE, SINTESI E VALUTAZIONE BIOLOGICA 353
A selective alpha1D-adrenoreceptor antagonist inhibits human prostate cancer cell proliferation and motility "in vitro" 299
Benzodioxane‐Benzamides as Antibacterial Agents : Computational and SAR Studies to Evaluate the Influence of the 7‐Substitution in FtsZ Interaction 255
2,6-Difluorobenzamide Inhibitors of Bacterial Cell Division Protein FtsZ : Design, Synthesis, and Structure Activity Relationships 223
Behavioural and pharmacological characterization of a novel cannabinomimetic adamantane-derived indole, APICA, and considerations on the possible misuse as a psychotropic spice abuse, in C57bl/6J mice 217
Benzodioxane–benzamides as new bacterial cell division inhibitors 213
Structure–affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of α1 antagonist WB-4101 205
Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective α1B-adrenoceptor antagonist 193
Processo di risoluzione di 2-ossazolidinoni racemici 190
Resolution of 5-hydroxymethyl-2-oxazolidinone by preferential crystallization[ 1 ] and investigations on the nature of the racemates of some 2-oxazolidinone derivatives 187
FOYE’S Principi di Chimica Farmaceutica: l'essenziale 181
3-(Benzodioxan-2-ylmethoxy)-2,6-difluorobenzamides bearing hydrophobic substituents at the 7-position of the benzodioxane nucleus potently inhibit methicillin-resistant Sa and Mtb cell division 177
How reaction conditions may influence the regioselectivity in the synthesis of 2,3-dihydro-1,4-benzoxathiine derivatives 177
QSAR study for a novel series of ortho monosubstituted phenoxy analogues of alpha(1)-adrenoceptor antagonist WB4101 172
Analytical approach for the identification of impurities, intermediates and precursor of the entactogen synthesis 171
Univocal syntheses of 2- and 3-hydroxymethyl-2,3-dihydro[1,4]dioxino[2,3-b]pyridine enantiomers 170
Chemistry and pharmacology of a series of unichiral analogues of 2-(2-pyrrolidinyl)-1,4-benzodioxane, prolinol phenyl ether and prolinol 3-pyridyl ether designed as alpha4beta2-nicotinic acetylcholine receptor agonists 170
A short entry to enantiopure 2-substituted 1,4-benzodioxanes by efficient resolution methods 168
Processo di risoluzione di un sale della carnitinammide 168
Shark-like chondroitin sulfate and process for the preparation thereof 162
Influence of (S)-1-phenylethylamine para substitution on the resolution of (±)-1,4-benzodioxane-2-carboxylic acid: a crystallographic, theoretical and morphologic approach 160
2-Hydroxymethyl-1,4-dioxane: synthesis, resolution and determination of the absolute configurations of the enantiomers 156
An investigation into the influence of counterion on the RS-Propranolol and S-Propranolol skin permeability 150
Synthesis and alpha 4 beta 2 nicotinic affinity of unichiral 5-(2-pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes 149
A highly efficient method for the alpha,beta-dehydrogenation of alpha-amino esters and alpha-amino-beta-diesters 146
Synthesis and a4b2 nicotinic affinity of the stereoisomers of 2-(1-methyl-2-pyrrolidinyl)-1,4-benzodioxane and of its nor-methyl derivative 145
Oral bioavailability and pharmacokinetics of nonanimal chondroitin sulfate and its constituents in healthy male volunteers 145
QSAR study for a novel series of ortho disubstituted phenoxy analogues of a1-adrenoceptor antagonist WB4101 143
Highly efficient resolutions of 1,4-benzodioxane-2-carboxylic acid with para substituted 1-phenylethylamines 142
ANALOGUES OF ALPHA1-ADRENOCEPTOR ANTAGONIST WB4101: DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION 141
6‑Methoxy-7-benzofuranoxy and 6‑Methoxy-7-indolyloxy Analogues of 2‑[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4- benzodioxane (WB4101) : 1 Discovery of a Potent and Selective α1D Adrenoceptor Antagonist 138
WB4101-related compounds: New, subtype-selective alpha(1)-adrenoreceptor antagonists (or inverse agonists?) 137
A process for the prepartion of coenzyme Q10 136
Process for the diastereoisomeric resolution of 5-Methyltetrahydrofolic acid 134
SYNTHESIS AND BINDING AFFINITY OF NEW HIGHLY SELECTIVE alpha4beta2 NICOTINIC LIGANDS 133
SYNTHESIS AND BINDING AFFINITY OF NEW HIGHLY SELECTIVE alpha4beta2 NICOTINIC LIGANDS 131
Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase 130
Design and synthesis of fluorescent-methylphenidate analogues for FRET-based assay of Synapsin III binding 130
Biotechnologica sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof 129
Characterization of in vitro metabolites of JWH-018, JWH-073 and their 4-methyl derivatives, markers of the abuse of these synthetic cannabinoids 129
Resolution of 1-phenyl-2-( p-tolyl)ethylamine via diastereomeric salt formation 128
Heteroaryl carnosine analogues: design, synthesis and carbonyl quenching activity 128
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NON-PEPTIDIC INHIBITORS OF FARNEYLTRANSFRERASE 127
The use of the naphthyl probe to scan the alpha-1A/5HT1A receptor binding sites: discovery of novel alpha-1A selective antagonists 126
Identification of 1-butyl-3-(1-(4-methyl)naphtoyl)indole detected for the first time in ‘‘herbal high’’ products on the Italian market 126
Detoxification of Ginkgo biloba seeds by home cooking and industrial processes: quantification of 4’-O-methylpiridoxine by HPLC-FLD 126
Unichiral 2-(2′-Pyrrolidinyl)-1,4-benzodioxanes : the 2R,2′S Diastereomer of the N-Methyl-7-hydroxy Analogue Is a Potent α4β2- and α6β2-Nicotinic Acetylcholine Receptor Partial Agonist 125
Exploring the space of histidine containing dipeptides in search of novel efficient RCS sequestering agents 125
FOLATES, COMPOSITIONS AND USES THEREOF 123
Simple process for the preparation of cetyltrimethylammonium naproxenate (naprocet) 123
How do reaction conditions affect the enantiopure synthesis of 2-substituted-1,4-benzodioxane derivatives? 123
Farnesyltransferase inhibitors : CAAX mimetics based on different biaryl scaffolds 121
Stressed degradation studies of domiphen bromide by LC-ESI-MS/MS identify a novel promising antimicrobial agent 121
Resolution of 2-substituted 1,4-benzodioxanes by entrainment 120
How to fight antimicrobial resistance: design and synthesis of FTSZ inhibitors as novel potent gram-positive antibiotics 120
A simple route to benzofuran-2(3H)-ones 118
ZINC SALT CATALYZED REARRANGEMENT OF ACETALS OF OPTICALLY-ACTIVE ARYL 1-CHLOROETHYL KETONES - SYNTHESIS OF OPTICALLY-ACTIVE 2-ARYLPROPIONIC ACIDS AND ESTERS 116
Structural and conformational studies on 5-[1'-methylpyrrolidin-2'-yl]-1,3-oxazolidin-2-one free base and hydrochloride form 115
From pregabalin to rac-3-cyano-5-methylhexanoic acid : an easy conversion which valorizes waste pregabalin enantiomer 114
Ginkgo biloba seeds in human diet: effect of domestic and industrial heating on ginkgotoxin content 113
Synthesis, free solution capillary electrophoresis separation and toxicity of seven potential impurities of dobutamine 113
Design, synthesis and binding affinity of acetylcholine carbamoyl analogues 109
null 109
Nuovo procedimento per la preparazione di derivati del glicerolo otticamente attivi 108
Synthesis of N,N'-dibenzylethylenediamine via palladium-carbon-catalysed reductive alkylation 107
From 2-aminomethyl-1,4-benzodioxane enantiomers to unichiral 2-cyano- and 2-carbonyl-substituted benzodioxanes via dichloroamine 107
Detection and quantification of several synthetic cannabinoids in human plasma by chromatography-mass specrtometry using two new non deuterated internal standards 107
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 107
Entrainment resolution of carnitinamide chloride 106
SEARCH FOR SELECTIVE ANTAGONISTS AT α1-ADRENORECEPTOR SUBTYPES: WB-4101 RELATED COMPOUNDS 106
Targeting bacterial cell division: A binding site-centered approach to the most promising inhibitors of the essential protein FtsZ 106
Diastereomeric 2-aminomethyl-1,4-benzodioxane mandelates : phase diagrams and resolution 105
Agonistic activity and charge driven intra- and intermolecular interaction potentiality of some PAF derivatives 105
Construction of human ghrelin receptor (hGHS-R1a) model using a fragmental prediction approach and validation through docking analysis 103
One-pot racemization process of 1-phenyl-1,2,3,4-tetrahydroisoquinoline : a key intermediate for the antimuscarinic agent solifenacin 103
Novel modulators of α-Synuclein / Synapsin-III interaction as potential antiparkinsonian agents 102
Battle against antimicrobial resistance: FtsZ inhibitors as novel potent Gram-positive antibiotics 101
A facile and efficient Synthesis of (o-Hydroxyaryl)-glycolic acid derivatives 100
Enantiomer systems of carnitinamide inorganic salts: introductory studies to a successful entrainment resolution 99
Modelling of full-length human α4β2 nicotinic receptor by fragmental approach and analysis of its binding modes 98
Computational Design and Development of Benzodioxane-Benzamides as Potent Inhibitors of FtsZ by Exploring the Hydrophobic Subpocket 97
Ferrous fructose-1,6-diphosphate, use, composition and process for the obtainment thereof 96
Synthesis and structure-activity relationship of novel inhibitors of the prokaryotic divisome protein FtsZ 96
Sviluppo e validazione di un metodo HPLC-FLD per la determinazione di 4’-O-metilpiridossina nei semi di Ginkgo biloba L. 96
Synthesis of (R)- and (S)-isopropylidene glycerol 95
Enhanced oral bioavailability of a novel folate salt : Comparison with folic acid and a calcium folate salt in a pharmacokinetic study in rats 95
Highly efficient racemisation of a key intermediate of the antibiotic moxifloxacin 94
PHYSICAL-PROPERTIES OF SULPIRIDE AND ITS (S)-ENANTIOMER 93
Structural analogues of methylphenidate as Parkinson's disease-modifying agents 93
Chiral PAF agonists: synthesis, theoretical analysis of their stereoelectronic properties and structure-activity relationships 92
Synthesis of (-)- and (+)-esermethole via chemical resolution of 1,3-dimethyl-3-(2-aminoethyl)-5-methoxyoxindole 92
Staphylococcus aureus RnpA Inhibitors: Computational-Guided Design, Synthesis and Initial Biological Evaluation 92
Peptidomimetic inhibitors of farnesyltransferase with high in vitro activity and significant cellular potency 91
Asymmetric aldol condensation of 1-Naphtol and pyruvares in presence of Lewis acids 91
Cardiovascular and pulmonary activity of platelet-activating factor (PAF-acether) and its derivatives 91
Relationships between conformational behaviour and binding affinity towards beta1 and beta2 adrenoceptors of some chiral phenoxypropanolamines with bulky N-substituents 90
A new convenient synthesis of 1-(4-nitrophenyl)ethylamine from acetophenone 90
ALKYLATION OF AROMATIC-COMPOUNDS WITH OPTICALLY-ACTIVE LACTIC-ACID DERIVATIVES - SYNTHESIS OF OPTICALLY PURE 2-ARYLPROPIONIC ACID AND ESTERS 90
Totale 14.115
Categoria #
all - tutte 40.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.785


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019279 0 0 0 0 0 0 0 0 0 0 129 150
2019/20202.173 239 146 72 170 139 235 262 148 295 256 113 98
2020/20211.792 41 199 129 72 193 110 81 112 175 151 360 169
2021/20222.165 150 88 55 106 174 107 460 79 169 126 193 458
2022/20232.473 388 279 256 263 249 392 117 140 213 38 84 54
2023/20241.256 64 165 76 122 278 134 92 134 48 85 58 0
Totale 16.871